On December 31, 2024, Cormorant Asset Management, LP (Trades, Portfolio) made a significant move by acquiring an additional 823,219 shares of Praxis Precision M
On December 31, 2024, Cormorant Asset Management, LP (Trades, Portfolio) made a strategic move by acquiring 609,027 shares of Kala Bio Inc at a price of $6.94 p
Baird initiated coverage of Bright Minds Biosciences (DRUG) with an outperform rating, citing the planned acquisition of rival Longboard Pharmaceuticals (LBPH). Read more here.
Cash Position: Cash, cash equivalents, and short-term investments totaled approximately $288.4 million as of September 30, 2024, indicating a strong liquidity
Overview of the Recent Transaction On November 6, 2024, FMR LLC (Trades, Portfolio) executed a significant transaction by reducing its holdings in Longboard Pha
It’s been one wild ride for Bright Minds Biosciences (NASDAQ: DRUG), which skyrocketed an eye-popping 5,900% this week! Yes, you read that right—nearly six
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.8% on Monday.
The Dow traded up 0.53% to 43,092.98 while the NASDAQ rose...
Shares of Longboard Pharmaceuticals, Inc. LBPH rose sharply in today's pre-market trading.
Lundbeck agreed to acquire Longboard Pharmaceuticals in a transactio...
Biohaven stock is not cheap, but the company's team is experienced. Read why investors should not be surprised if the upside momentum continues for BHVN stock.
Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercialization of neffy® in the U.S.,...